Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Abbott Gains FDA Approval for CardioMEMS Update Letting Heart Failure Patients View ...

8 October 2026 · By · Wire by Fusion42

Published

8 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at patientcareonline.com →

◆ Verified

Fusion42 · 10 October 2026 · Fusion42 review

Abbott received FDA approval for updates to the CardioMEMS HF System, enabling heart failure patients to view their pulmonary artery pressure readings and receive personalized medication instructions via a smartphone app.

This Wire brief sits within Fusion42's coverage of Medtech, and 5 sources have reported it between 5 Oct 2026 and 8 Oct 2026.

◆ ◆ The Wire takeaway

You gain a new route to engage heart failure patients directly through Abbott's approved app, creating opportunities to build supportive services around patient self-monitoring and treatment adherence.

◆ Coverage

5 sources · first reported 5 Oct 2026 · latest 8 Oct 2026

◆ Related on Wire

◆ Topics

MedtechFDA-approvalheart-failureremote-monitoringpatient-engagementdigital-health